GB202000840D0 - Compositions and methods - Google Patents

Compositions and methods

Info

Publication number: GB202000840D0
Authority: GB; United Kingdom
Prior art keywords: compositions; methods
Prior art date: 2020-01-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB2000840.5A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

CELL GUIDANCE SYSTEMS Ltd

Cambridge Enterprise Ltd

Original Assignee

CELL GUIDANCE SYSTEMS Ltd

Cambridge Enterprise Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2020-01-21

Filing date

2020-01-21

Publication date

2020-03-04

2020-01-21 Application filed by CELL GUIDANCE SYSTEMS Ltd, Cambridge Enterprise Ltd filed Critical CELL GUIDANCE SYSTEMS Ltd

2020-01-21 Priority to GBGB2000840.5A priority Critical patent/GB202000840D0/en

2020-03-04 Publication of GB202000840D0 publication Critical patent/GB202000840D0/en

2021-01-18 Priority to EP21702301.9A priority patent/EP4093425A1/en

2021-01-18 Priority to PCT/GB2021/050112 priority patent/WO2021148779A1/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Orthopedic Medicine & Surgery (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

GBGB2000840.5A 2020-01-21 2020-01-21 Compositions and methods Ceased GB202000840D0 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
GBGB2000840.5A GB202000840D0 (en)	2020-01-21	2020-01-21	Compositions and methods
EP21702301.9A EP4093425A1 (en)	2020-01-21	2021-01-18	Polyhedrin delivery system releasing growth factors
PCT/GB2021/050112 WO2021148779A1 (en)	2020-01-21	2021-01-18	Polyhedrin delivery system releasing growth factors

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB2000840.5A GB202000840D0 (en)	2020-01-21	2020-01-21	Compositions and methods

Publications (1)

Publication Number	Publication Date
GB202000840D0 true GB202000840D0 (en)	2020-03-04

Family

ID=69636764

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB2000840.5A Ceased GB202000840D0 (en)	2020-01-21	2020-01-21	Compositions and methods

Country Status (3)

Country	Link
EP (1)	EP4093425A1 (en)
GB (1)	GB202000840D0 (en)
WO (1)	WO2021148779A1 (en)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6911212B2 (en)	1998-02-27	2005-06-28	Musculoskeletal Transplant Foundation	Malleable putty and flowable paste with allograft bone having residual calcium for filling bone defects
US7432347B2 (en)	2000-10-30	2008-10-07	Protein Crystal Co., Ltd	Cytoplasmic polyhedrosis virus polyhedrin protein complex
WO2004063371A1 (en)	2003-01-10	2004-07-29	Protein Crystal Co., Ltd.	Protein complex, process for producing the same and use thereof
US8554493B2 (en)	2007-02-28	2013-10-08	National University Corporation Kyoto Institute Of Technology	Viral polyhedra complexes and methods of use
US8916228B2 (en)	2007-08-09	2014-12-23	The Board Of Regents Of The University Of Texas System	Bi-layered bone-like scaffolds
WO2012096997A2 (en)	2011-01-10	2012-07-19	Biomimedica, Inc.	Orthopedic implants having gradient polymer alloys
SG11201507751YA (en)	2013-03-21	2015-10-29	Eupraxia Pharmaceuticals USA LLC	Injectable sustained release composition and method of using the same for treating inflammation in joints and pain associated therewith
GB201705955D0 (en)	2017-04-13	2017-05-31	Cell Guidance Systems Ltd	Delivery method
GB201708233D0 (en)	2017-05-23	2017-07-05	Orthox Ltd	Implantable tissue repair devices and methods for manufacturing the same

2020
- 2020-01-21 GB GBGB2000840.5A patent/GB202000840D0/en not_active Ceased
2021
- 2021-01-18 WO PCT/GB2021/050112 patent/WO2021148779A1/en not_active Ceased
- 2021-01-18 EP EP21702301.9A patent/EP4093425A1/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP4093425A1 (en)	2022-11-30
WO2021148779A1 (en)	2021-07-29

Publication	Publication Date	Title
GB202111040D0 (en)	2021-09-15	Compositions and methods
IL290325A (en)	2022-04-01	Biopharmacuetical compositions and related methods
GB202004677D0 (en)	2020-05-13	Methods and compositions
IL323067A (en)	2025-10-01	Serpina-modulating compositions and methods
GB202108585D0 (en)	2021-07-28	Methods and compositions
IL304824A (en)	2023-09-01	Fospropofol methods and compositions
GB202316199D0 (en)	2023-12-06	Compositions and methods and uses thereto
CA3260587A1 (en)	2023-12-28	Fah-modulating compositions and methods
GB202110091D0 (en)	2021-08-25	Methods and compositions
SG11202108262VA (en)	2021-08-30	Bacterialcidal methods and compositions
GB202002926D0 (en)	2020-04-15	Compositions and uses thereof
GB202408093D0 (en)	2024-07-24	Compositions and methods
GB202214719D0 (en)	2022-11-23	Compositions and methods
IL310092A (en)	2024-03-01	Compositions and methods
GB202116554D0 (en)	2021-12-29	Methods and compositions
GB202113904D0 (en)	2021-11-10	Methods and compositions
GB202110572D0 (en)	2021-09-08	Compositions and methods
GB202105367D0 (en)	2021-06-02	Methods and compositions
GB202101962D0 (en)	2021-03-31	Methods and compositions
GB202020623D0 (en)	2021-02-10	Methods and compositions
GB202013858D0 (en)	2020-10-21	Compositions and methods
GB202009256D0 (en)	2020-07-29	Compositions and methods
GB202002707D0 (en)	2020-04-08	Compositions and methods
GB202001526D0 (en)	2020-03-18	Methods and compositions
GB202000840D0 (en)	2020-03-04	Compositions and methods

Legal Events

Date	Code	Title	Description
2021-08-18	AT	Applications terminated before publication under section 16(1)